H.C. Wainwright analyst Sara Nik initiated coverage of Pasithea Therapeutics (KTTA) with a Buy rating and $3 price target The firm says the ...

Cash crops (such as coffee, cotton, sugarcane, soybean, grape, wheat, tomato, etc.) serve as a vital pillar of the global agricultural economy and a key ...

Summary • Erasca, Inc. (ERAS) shares rose 14.1% to $3.30 amid conference participation.• The company is attending the Evercore Healthcare Conference to discuss RAS/MAPK therapy advancements.• Analysts ...

Pasithea Therapeutics Corp ( ($KTTA) ) has shared an update. On November 28, 2025, Pasithea Therapeutics Corp announced a public offering of ...

Extends cash runway through at least the first half of 2028Led by healthcare-dedicated investors, including Vivo Capital, Janus Henderson ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

Erasca, Inc. (NASDAQ:ERAS) is one of the 12 hot penny stocks to invest in right now. On November 14, 2025, Erasca, Inc.

The human body experiences various health problems because of inflammation, which can lead to joint pain, heart disease and ...

In this piece, we will discuss the 12 hot penny stocks to invest in right now. Amid an uncertain macro environment, where the economic outlook is blurry, the momentum of penny stocks depends heavily ...

Pasithea Therapeutics Corp (NASDAQ: KTTA) shares are trading sharply higher Wednesday following a string of upbeat updates.

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic insights to deliver more effective, resilient, and personalized therapies.

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the Piper ...